Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal motor neuron degenerative disease, and it is hard to diagnose in the early stage, and treatment means are limited, and the treatment effect is unsatisfactory. Therefore, exploring a new effective treatment strategy is urgently needed for...
Guardado en:
Autores principales: | Ke Wang, Yu Li, Chao Ren, Yongjing Wang, Wenshan He, Yuan Jiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2df7ed3651d94027b14a51bfe69adeef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyotrophic lateral sclerosis official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
Publicado: (2006) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000) -
Amyotrophic lateral sclerosis and other motor neuron disorders official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
Publicado: (2005) -
A Platform to Understand Amyotrophic Lateral Sclerosis (ALS) and Extend Human Motor Neurons Longevity
por: Cáceres,D. E, et al.
Publicado: (2019) -
γ' Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis
por: Ana Catarina Pronto-Laborinho, et al.
Publicado: (2021)